Circadian Design now taking pre-orders for Round Refill medication delivery service with smart bottle
Targets $289 billion annual cost to US healthcare system.
Circadian Design has announced it is taking pre-orders for Round Refill, the first pharmacy delivery service that comes with a smart bottle for medication and vitamins. Round Refill follows the success of Round Health, a medicine reminder and pill tracker smartphone app. The company aims to tackle patients’ poor adherence to their doctor’s orders on timing, dosage, and frequency of taking their medication, estimated to cost the US healthcare system up to $289 billion a year, according to research published in the Annals of Internal Medicine.
Round Refill is a premium medication reminder system that helps people be better about taking their pills day-to-day and refill-to-refill. It’s the first pharmacy delivery service integrated with a smart bottle and app. The bottle lights up to remind users when to take their medication and tracks how many pills are left so refills are delivered to the home only when needed.
“Whether you are a senior citizen or a kid just out of college, there is nothing easy about navigating the healthcare system,” said Circadian Design CEO and Co-Founder Matt Blum. “Many people would rather do laundry than take medications prescribed to them. Thus the mission of Circadian Design is to make people happier and healthier through a foolproof customer experience that’s easy and well-designed.”
Nearly half of the US population – over 160 million people – is prescribed to take one or more drug per year by their doctor, according the National Center for Health Statistics. But research published in The New England Journal of Medicine indicates more than half of those people do not follow their doctor’s instructions and take medications incorrectly or skip them entirely. Adherence is not just a senior moment: a recent study by HealthPrize Technologies LLC reported 60% of Millennials on medication for a chronic condition admitted to not taking their medication as prescribed.
Non-adherence is a big issue because of the obvious poor health outcomes. Medications don’t work if patients don’t take them. For example, according to an article published in the journal Medical Care, people with high blood pressure are 42% more likely to develop chronic heart failure if they don't adhere to their antihypertensive.
“Medication adherence is a tremendous problem that costs the US healthcare system billions of dollars every year,” said Circadian Design Investor Max Levchin. “Besides the simple convenience Round Refill affords, Circadian’s team has the unique experience in hardware and design to launch an elegant solution that we believe will have a far-reaching impact on the adherence problem for many years to come.”
Round Bottle comprises two parts: the smart coin, which users hold onto for years, and the refill bottle, which users receive new every month. The refill bottle comes loaded with the medication and a fresh battery inside, so that users never have to charge the smart coin. When one bottle runs out, users simply pop their smart coin into the new refill bottle that was delivered to their doorstep.
Compared to typical phone alarms, Round’s daily reminders are even more accommodating to users’ busy lives, and, as a result, are more effective. Rather than discrete alarms, with Round users set reminder windows during which they’d like to receive gentle reminders to take their medication. In addition to Round app notifications, Round Bottle lights up to remind users to take their pills. Each time the bottle is opened, it is automatically logged to the app via Bluetooth. In the app, users can check to see if they took their medication and look back at their history and performance.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.